^
    over1year
    Analytical Validation of the BCR-ABL p190 Transcripts Using GeneXpert Dx System (AMP 2022)
    The Cepheid Xpert p190 RUO assay demonstrated excellent laboratory performance on both clinical and contrived materials as compared to the laboratory test of record. The simplicity of the assay also allows for decreased turnaround, less hands-on time, and fewer required technical skills which may enable increased laboratory efficiencies over conventional methods.
    ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase)
    |
    BCR-ABL1 fusion
    |
    Xpert® BCR-ABL Ultra • ipsogen BCR-ABL1 mbcr Kit
    over2years
    [VIRTUAL] Method Comparison between Two Commercially Available BCR-ABL1 Quantitative Kits (AMP 2021)
    The 2 kits were highly correlated over the full range of values obtained. Some bias was observed, arising from differences in quantifying e13a2. Qualitative agreement of detection was high, but interpretation was complicated by replicate-discrepant BCR-ABL1 results
    ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase)
    |
    BCR-ABL1 fusion
    |
    Quantidex qPCR BCR-ABL IS Kit • ipsogen BCR-ABL1 mbcr Kit